These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28959472)

  • 1. Low-dose intravenous tissue plasminogen activator for acute ischaemic stroke: an alternative or a new standard?
    Dong Y; Cao W; Cheng X; Fang K; Wu F; Yang L; Xie Y; Dong Q
    Stroke Vasc Neurol; 2016 Sep; 1(3):115-121. PubMed ID: 28959472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Who may benefit from lower dosages of intravenous tissue plasminogen activator? Results from a cluster data analysis.
    Dong Y; Han Y; Shen H; Wang Y; Ma F; Li H; Wang Y; Dong Q
    Stroke Vasc Neurol; 2020 Dec; 5(4):348-352. PubMed ID: 32611728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis.
    You S; Saxena A; Wang X; Tan W; Han Q; Cao Y; Liu CF
    Stroke Vasc Neurol; 2018 Mar; 3(1):22-27. PubMed ID: 29600004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review.
    Wang X; You S; Sato S; Yang J; Carcel C; Zheng D; Yoshimura S; Anderson CS; Sandset EC; Robinson T; Chalmers J; Sharma VK
    Stroke Vasc Neurol; 2018 Mar; 3(1):28-33. PubMed ID: 29600005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Cheng JW; Zhang XJ; Cheng LS; Li GY; Zhang LJ; Ji KX; Zhao Q; Bai Y
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):381-390. PubMed ID: 29111341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Taking Warfarin with Subtherapeutic INR.
    Mowla A; Memon A; Razavi SM; Lail NS; Vaughn CB; Mohammadi P; Sawyer RN; Shirani P
    J Stroke Cerebrovasc Dis; 2021 May; 30(5):105678. PubMed ID: 33640783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.
    Ong CT; Wong YS; Wu CS; Su YH
    Drug Des Devel Ther; 2017; 11():1559-1566. PubMed ID: 28572721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of intravenous tissue plasminogen activator and hospital costs for patients with acute ischaemic stroke aged 18-64 years in the USA.
    Joo H; Wang G; George MG
    Stroke Vasc Neurol; 2016 Mar; 1(1):8-15. PubMed ID: 27547449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke Thrombolysis in Patients Taking Ticagrelor -Two Successful Cases and a Review of the Literature.
    Landzberg DR; English S; Frankel M; Navalkele D
    J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105520. PubMed ID: 33310594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating ischaemic stroke with intravenous tPA beyond 4.5 hours under the guidance of a MRI DWI/T2WI mismatch was safe and effective.
    Bai QK; Zhao ZG; Lu LJ; Shen J; Zhang JY; Sui HJ; Xie XH; Chen J; Yang J; Chen CR
    Stroke Vasc Neurol; 2019 Mar; 4(1):8-13. PubMed ID: 31105973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics, management and response to alteplase in China versus non-China participants of the ENCHANTED trial.
    Song L; Wang X; Robinson T; Lindley RI; Arima H; Lavados PM; Chen X; Chalmers J; Anderson CS
    Stroke Vasc Neurol; 2017 Jun; 2(2):53-58. PubMed ID: 28959492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors of haemorrhagic transformation for acute ischaemic stroke in Chinese patients receiving intravenous recombinant tissue plasminogen activator: a systematic review and meta-analysis.
    Guo Y; Yang Y; Zhou M; He L
    Stroke Vasc Neurol; 2018 Dec; 3(4):203-208. PubMed ID: 30637125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of multimodal MRI-guided intravenous thrombolysis in patients with stroke with unknown time of onset.
    Zhao J; Zhao H; Li R; Li J; Liu C; Lv J; Li Y; Liu W; Ma D; Hao H; Xiao X; Liu J; Yin Y; Liu R; Yu Q; Wei Y; Li P; Wang Y; Wang R
    Stroke Vasc Neurol; 2019 Mar; 4(1):3-7. PubMed ID: 31105972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of intravenous thrombolysis for acute ischemic stroke in Asia.
    Sharma VK; Ng KW; Venketasubramanian N; Saqqur M; Teoh HL; Kaul S; Srivastava PM; Sergentanis T; Suwanwela N; Nguyen TH; Lawrence Wong KS; Chan BP
    Int J Stroke; 2011 Dec; 6(6):523-30. PubMed ID: 22111797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of intravenous r-tPA versus UK for acute ischaemic stroke: a nationwide prospective Chinese registry study.
    Wang X; Li X; Xu Y; Li R; Yang Q; Zhao Y; Wang F; Sheng B; Wang R; Chen S; Wang L; Shen L; Hou X; Cui Y; Wang D; Peng B; Anderson CS; Chen H;
    Stroke Vasc Neurol; 2021 Dec; 6(4):603-609. PubMed ID: 33903179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous thrombolysis with tissue-plasminogen activator in small vessel occlusion.
    Paek YM; Lee JS; Park HK; Cho YJ; Bae HJ; Kim BJ; Park JM; Lee SJ; Cha JK; Park TH; Lee KB; Lee J; Lee BC; Kim JT; Kim DE; Shin DI; Kim WJ; Sohn SI; Choi JC; Hong KS
    J Clin Neurosci; 2019 Jun; 64():134-140. PubMed ID: 30952555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Chinese Stroke Association scientific statement: intravenous thrombolysis in acute ischaemic stroke.
    Dong Q; Dong Y; Liu L; Xu A; Zhang Y; Zheng H; Wang Y
    Stroke Vasc Neurol; 2017 Sep; 2(3):147-159. PubMed ID: 28989804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Inflammation Indices in Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator: Clinical Yield and Utility.
    Topcuoglu MA; Pektezel MY; Yilmaz E; Arsava EM
    Angiology; 2021 Mar; 72(3):279-284. PubMed ID: 33153275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Outcomes of Intravenous tPA in Acute Ischemic Stroke Patients With Prior Stroke Within 3 Months: Findings From Get With The Guidelines-Stroke.
    Shah S; Liang L; Kosinski A; Hernandez AF; Schwamm LH; Smith EE; Fonarow GC; Bhatt DL; Feng W; Peterson ED; Xian Y
    Circ Cardiovasc Qual Outcomes; 2020 Jan; 13(1):e006031. PubMed ID: 31903770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Outcomes of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients with COVID-19: CASCADE Initiative.
    Sasanejad P; Afshar Hezarkhani L; Arsang-Jang S; Tsivgoulis G; Ghoreishi A; Barlinn K; Rahmig J; Farhoudi M; Sadeghi Hokmabadi E; Borhani-Haghighi A; Sariaslani P; Sharifi-Razavi A; Ghandehari K; Khosravi A; Smith C; Nilanont Y; Akbari Y; Nguyen TN; Bersano A; Yassi N; Yoshimoto T; Lattanzi S; Gupta A; Zand R; Rafie S; Pourandokht Mousavian S; Reza Shahsavaripour M; Amini S; Kamenova SU; Kondybayeva A; Zhanuzakov M; Macri EM; Nobleza COS; Ruland S; Cervantes-Arslanian AM; Desai MJ; Ranta A; Moghadam Ahmadi A; Rostamihosseinkhani M; Foroughi R; Hooshmandi E; Akhoundi FH; Shuaib A; Liebeskind DS; Siegler J; Romano JG; Mayer SA; Bavarsad Shahripour R; Zamani B; Woolsey A; Fazli Y; Mojtaba K; Isaac CF; Biller J; Di Napoli M; Azarpazhooh MR
    J Stroke Cerebrovasc Dis; 2021 Dec; 30(12):106121. PubMed ID: 34601242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.